UC OSHA 300 log summary available
The record, which includes occupational injury and illness totals that occurred at UC in 2018, includes summaries available for the Uptown West and Medical campuses, UC Blue Ash and Clermont colleges
Contact: Jan Utrecht: 513-556-4968
The UC OSHA 300 Log Summary includes occupational injury and illness totals that occurred at UC in 2018. Summaries are available for the Uptown West and Medical campuses, UC Blue Ash, and Clermont Colleges.
Managers are required to share the university’s OSHA 300 Log Summary with employees. The OSHA 300 Log summary of work-related injuries and illnesses is required by regulations to be posted annually from Feb. 1 through April 30.
This summary is a record of the calendar year 2018 occupational injury and illness totals that occurred at the University of Cincinnati. Summaries are available for the Uptown West and Medical Campuses, UC Blue Ash College, and UC Clermont College. Be sure to post the summary that represents your area in a conspicuous place or places where notices to your employees are customarily posted.
Access your summary from Enviornmental Health and Safety's web site at www.ehs.uc.edu.
Featured image: Professor Rashmi Jha and student Tommy engaging in some research in Clean Room at ERC. UC/Joseph Fuqua II
Tags
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.